[New Product] Completion of Development and Launch of KGF Alternative Peptide (FGFR2b agonist)
2025/04/01
We have successfully developed a peptide that demonstrates high affinity and agonist activity against FGFR2b (Fibroblast growth factor receptor 2b), similar to KGF (Keratinocyte growth factor). Starting from April 2025, we will start selling the KGF Alternative Peptide (FGFR2b Agonist) under the product code "PG-012".
PG-012 is intended to be used in the field of regenerative medicine and cell therapy, particularly in applications such as differentiation and proliferation of epidermal cells and cells derived from the endoderm, such as alveolar epithelial cells, islet cells, and hepatocytes, from pluripotent stem cells.
We can provide the free sample. Please feel free to contact us from [contact].
